24 companies · FY2026 results (annual securities reports)
Nxera ranks first for average salary in the Pharmaceutical industry at ¥12.6M. The top three are Nxera (¥12.6M), Chugai (¥12.1M) and Peptide Dream (¥11.7M).
Across the 24 companies the average is ¥9.57M and the median ¥9.28M. Towa comes last at ¥6.95M, a gap of about 1.8x to the leader.
11 of 24 companies are above the average. 10 pay an average of ¥10M or more.
Pharmaceutical Industry TOP3
Shares 1Y is a closing-price reference (vs. about a year earlier).
| Rank | Company | Average salary | Revenue | Operating profit | Operating margin |
|---|---|---|---|---|---|
| 1 | Nxera4565 | ¥12.6M | ¥29.6B | ¥-8.5B | -28.6% |
| 2 | Chugai4519 | ¥12.1M | ¥1.3T | ¥598.8B | 47.6% |
| 3 | Peptide Dream4587 | ¥11.7M | ¥18.5B | ¥-5.0B | -27.1% |
| 4 | Eisai4523 | ¥11.2M | ¥825.4B | ¥44.1B | 5.3% |
| 5 | Takeda4502 | ¥11.0M | ¥4.5T | ¥408.8B | 9.1% |
| 6 | Daiichi Sankyo4568 | ¥11.0M | ¥2.1T | ¥229.1B | 10.8% |
| 7 | Otsuka4578 | ¥10.6M | ¥2.5T | ¥479.4B | 19.4% |
| 8 | Astellas4503 | ¥10.5M | ¥2.1T | ¥382.6B | 17.9% |
| 9 | Ono4528 | ¥10.2M | ¥515.8B | ¥92.2B | 17.9% |
| 10 | Shionogi4507 | ¥10.0M | ¥499.7B | ¥166.7B | 33.4% |
| 11 | Kyowa Kirin4151 | ¥9.94M | ¥496.8B | - | - |
| 12 | Sawai4887 | ¥9.38M | ¥201.7B | ¥15.9B | 7.9% |
| 13 | Nippon Shinyaku4516 | ¥9.19M | ¥170.8B | ¥35.5B | 20.8% |
| 14 | Tsumura4540 | ¥9.11M | ¥192.6B | ¥35.2B | 18.3% |
| 15 | Sumitomo Pharma4506 | ¥9.06M | ¥453.3B | ¥107.3B | 23.7% |
| 16 | Santen4536 | ¥9.02M | ¥291.6B | ¥47.8B | 16.4% |
| 17 | Kaken4521 | ¥8.75M | ¥76.9B | ¥-899M | -1.2% |
| 18 | Rohto4527 | ¥8.26M | ¥343.7B | ¥41.1B | 12.0% |
| 19 | JCR4552 | ¥8.19M | ¥40.3B | ¥555M | 1.4% |
| 20 | Zeria4559 | ¥7.99M | ¥89.2B | ¥12.4B | 13.9% |
| 21 | Kissei4547 | ¥7.98M | ¥97.4B | ¥-2.9B | -3.0% |
| 22 | Kobayashi4967 | ¥7.57M | ¥165.7B | ¥14.9B | 9.0% |
| 23 | Suzuken9987 | ¥7.45M | ¥2.5T | ¥36.4B | 1.5% |
| 24 | Towa4553 | ¥6.95M | ¥273.7B | ¥23.1B | 8.4% |
Revenue and operating profit are from the latest full-year consolidated results. Average salary is for the reporting entity per its annual securities report; pure holding companies with fewer than 50 staff are excluded.
